bg
T

Taysha Gene Therapies (TSHA)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Taysha Gene Therapies (TSHA)

Taysha Gene Therapies, Inc. is a patient-centric gene therapy company. The Company is focused on developing and commercializing adeno-associated virus (AAV)-based gene therapies for the treatment of monogenic diseases of the central nervous system (C... Read more

  • USD3.16
  • USD3.30
  • USD2.86
  • USD3.89
  • 29.40%
  • 15M
  • 4.20M
  • 3.83M
  • 608M
  • 0.50
  • 356.10%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.